Atlas Trials

Plexiform Neurofibromas

11 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Plexiform Neurofibromas

RecordFirmDate
HL-085 in Adults With Neurofibromatosis Type 1 (NF1) and Inoperable Plexiform Neurofibromas (NCT05331105)Shanghai Kechow Pharma, Inc.2021-10-18
US Selumetinib Registry (NCT05683678)Alexion Pharmaceuticals, Inc.2019-01-04
Targeting the Mechanisms Underlying Cutaneous Neurofibroma Formation in NF1: A Clinical Translational Approach. (NCT02777775)Corewell Health West2016-05-01
Development and Validation of Patient Reported Outcome (PRO) Measures for Individuals With Neurofibromatosis 1 (NF1) and Plexiform Neurofibromas (pNFs) (NCT02544022)National Cancer Institute (NCI)2015-11-13
Acceptance and Commitment Training for Adolescents and Young Adults With Neurofibromatosis Type 1, Plexiform Neurofibromas, and Chronic Pain (NCT02471339)National Cancer Institute (NCI)2015-07-07
Study of Imatinib Mesylate in Neurofibromatosis Type I Patients Aged 2 to 21 With Plexiform Neurofibromas (NCT02177825)St. Justine's Hospital2014-06-01
Study of Sutent®/Sunitinib (SU11248) in Subjects With NF-1 Plexiform Neurofibromas (NCT01402817)Indiana University2012-03-01
Study of Plexiform Neurofibromas in Neurofibromatosis Type 1 (NCT00006435)National Cancer Institute (NCI)2001-05-18

Track Plexiform Neurofibromas automatically

Every clearance here is in the API, with alerts when new ones post.